logo
Ford CEO Jim Farley: Demand Isn't There for Big EV Trucks & SUVs Yet

Ford CEO Jim Farley: Demand Isn't There for Big EV Trucks & SUVs Yet

Yahoo06-02-2025
You can't fault Ford for trying, but it seems that its decision to kick off its electric vehicle plans with the likes of the F-150 Lightning is taking its financial toll on the Dearborn-based automaker. On Wednesday, Ford CEO Jim Farley took to the proverbial stage during the company's fourth-quarter earnings call to say in no uncertain terms that the current stage of EV manufacturing wasn't sustainable.
"For larger retail, electric utilities, the economics are unresolvable," Farley said in the earnings call, according to InsideEVs, referring to big EV SUVs and pickup trucks. "These customers have very demanding use cases for an electric vehicle. They tow, they go off-road, they take long road trips. These vehicles have worse aerodynamics and they're very heavy, which means very large and expensive batteries."
Considering gas-powered pickup truck and full-size SUVs have been Detroit's bread and butter for ages, it wasn't surprising that FoMoCo targeted the category for one of its first volleys into the EV market. Indeed, they're hardly alone; Ford, Chevrolet, GMC, Rivian, and Tesla all crank out some version of all-electric pickup here in 2025, and more are coming from the likes of Scout Motors and beyond. But the big EV utility vehicle market that manufacturers initially relied on isn't as strong as automakers had been counting on.
"Retail customers have shown that they will not pay any premium for these large EVs, making them a really tough business case," Farley said.
The lowest-trim F-150 Lightning starts at $49,875, making it not terribly expensive in the grand scheme of truck sticker costs. However, a comparable internal-combustion F-150 starts at $10,000 less — and generally speaking, Lightnings cost around $13,000 more than their gas-powered crew-cab F-150 equivalents. Meanwhile, Chevy's bulky Silverado EV starts at $75,195, roughly $20,000 more than the four-door short-bed Silverado 1500 LT that serves as a direct ICE comparison, and Tesla's Cybertruck only builds on that with a $79,990 sticker price.
And the production costs may not be worthwhile for Ford. Reporting from Bloomberg suggests that Ford is losing significant money on its EV programs, which in turn has contributed to the automaker's stock decline over the course of 2024. Analysis of Ford's Model E-business earnings shows the electric wing of the automaker at a $5 billion deficit for 2024, in addition to $1.9 billion in development costs. Ford's Rouge complex in Michigan, where the F-150 Lightning is produced, was shut down for two months at the tail-end of 2024, too. It wasn't until the automaker started to offer $2000 home chargers for free that EV sales came out of hibernation, rising fourth quarter EV sales by 16 percent after an extended period of dealer lot stagnation.
"We have observed lower-than-anticipated industry-wide electric vehicle adoption rates and near-term pricing pressures," Security and Exchange Commission documents filed by Ford on February 6, 2025, read. "The trend may be exacerbated as a policy change in the United States could reduce or eliminate supply- and demand-side incentives, resulting in slower adoption of EVs."
"Battery costs remain high, which is detrimental to electric vehicles reaching pricing parity with ICE vehicles and further exacerbates the pricing pressures on electric vehicles. Furthermore, as we invest in battery production, including the construction of battery plants, if we are unable to operate those plants at their expected capacity because electric vehicle adoption rates remain lower than anticipated or otherwise, we may be unable to recoup the investments we have made."
Ford has a plan to dig their way out of this EV spiral, however. Instead of building a previously promised three-row EV SUV, Ford is refocusing on a line of more accessible EVs priced around the $30,000 mark, Farley explained. The company is aiming to compete with the long-rumored affordable Tesla model — a vehicle that has endured through multiple waves of Elon Musk's chatoic decision-making process — and the legacy automaker is doing so in a start-up-like way, employing a former Tesla executive and a "skunkworks" team of engineers.
In addition, Bloomberg states that Farley revealed last month that Ford's future EVs will benefit from the availability of a on-board ICE generator used for on-the-fly charging — a powertrain layout known as an extended-range electric vehicle, or EREV. This isn't new technology — BMW would point to its original i3, and locomotives have been using similar tech for nearly a century — but it is finding new life these days. Stellantis will likely beat Ford to the punch, as the incoming Ram 1500 Ramcharger employs the technology, and Scout is set to be the second as the Terra SUV and Traveler pickup launches in 2027.
In the meantime, Ford will continue to temper its EV infrastructure investments and focus on commercial offerings, like the popular E-Transit van. Bottom line, it's still early for electric vehicles — and automakers are still working to figure out the best strategy for shareholders and customers alike.
You Might Also Like
You Need a Torque Wrench in Your Toolbox
Tested: Best Car Interior Cleaners
The Man Who Signs Every Car
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Pioneering Advances Reshape the Future of Live Cell Imaging
Pioneering Advances Reshape the Future of Live Cell Imaging

Time Business News

time23 minutes ago

  • Time Business News

Pioneering Advances Reshape the Future of Live Cell Imaging

Live cell imaging is a technique that is used to study living cells in real time, using advanced imaging systems such as fluorescence or confocal microscopy. This allows researchers to inspect cellular processes such as movement, division and interaction without interrupting cells. The market for live cell imaging is increasing due to increasing demand to detect early disease, increase in research in cancer and neurobiology, progress in imaging technologies and more investment in cell-based drug search. Additionally, the growth of personal medical and stem cell research is further enhancing its adoption in both academic and drug fields. Key Growth Drivers and Opportunities Increasing Demand for Detection of Early Disease: The increasing demand for initial disease detection is increasing the increase in live cell imaging market, as this technique enables the real -time view of cellular behavior, which helps researchers to identify abnormalities in early stages. In the progression of the disease, initial insight, especially in cancer, neurodegenerative, and infectious diseases, allow rapid diagnosis and more effective treatment development. It is an accurate, real -time real -time cellular data requiring, which advancing healthcare and research institutes to adopt advanced live cell is imaging systems, promoting market expansion. Challenges Live cell imaging markets face boundaries such as high equipment and maintenance costs, which can restrict adoption between small research laboratories and institutions. Additionally, the complexity of the imaging system requires efficient personnel for operation and data analysis, which is a challenge in resource-limited settings. Live imaging can also affect cell viability over time due to phototoxicity and environmental disturbances, which can affect the result accuracy. Limited standardization and fertility on platforms obstruct the extensive clinical application. Innovation and Expansion An Innovative Live-Cell Imaging System Is Unveiled by a Durham Startup In February 2025, A live-cell imaging system that greatly increases speed and throughput for cell analysis has been introduced by Ramona, a Durham-based supplier of cutting-edge imaging equipment for the life sciences. Ramona wants to raise the bar for throughput speeds and standards using Vireo. Vireo can evaluate a 96-well plate with five channels in less than two minutes, according to the firm. After a year-long early access program for research institutes, the product will be commercially released. The Neuroscience Center and the Carolina Institute for Development Disabilities are two early users at the UNC School of Medicine. For real-time cell analysis, Nanolive introduces the LIVE Cell Death Assay In September 2022, The LIVE Cell Death Assay, a push-button, automated solution for label-free cell health, death, apoptosis, and necrosis profiling, is another revolutionary instrument in the field of cell analysis from Nanolive. First-in-class cytotoxicity analysis of dynamic label-free live cell data is offered by the LIVE Cell Death Assay (LCDA). The LCDA was created with cutting-edge machine learning techniques and has been trained to distinguish between necrosis and apoptosis in addition to living and dead cells. The LCDA is designed to be as easy to use as feasible; all it takes is one button click to begin the analysis. It provides 13 indicators linked to viability and death. Inventive Sparks, Expanding Markets Prominent players working in the live cell imaging market include Thermo Fisher Scientific Inc., Revilit., Nikon Corporation Healthcare, Zes Group and others. Investing in technology innovations involves AI-operated image analysis, super-resolution microscopy, and automation to improve productivity and accuracy, one of the main initiatives for live cell imaging businesses. Business will focus on enhancing your product line by creating affordable and intuitive solutions for a series of research uses, serving both large pharmaceutical firms and small academic laboratories. About Author: Prophecy is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business. TIME BUSINESS NEWS

China plans subsidy vouchers for seniors to ease strain on its aging population, drive consumption
China plans subsidy vouchers for seniors to ease strain on its aging population, drive consumption

CNBC

time23 minutes ago

  • CNBC

China plans subsidy vouchers for seniors to ease strain on its aging population, drive consumption

China is planning to offer subsidy coupons to seniors in a rare use of direct fiscal support as Beijing seeks to ease the financial strain on its aging population and drive consumption of elderly-care services. The allowances will be paid monthly in the form of electronic coupons to cover part of the costs for seniors' care services, according to a joint statement issued by the ministry of civil affairs and ministry of finance on Wednesday. Chinese policymakers have avoided direct cash handouts similar to what the U.S. and Hong Kong offered during the pandemic to stimulate spending, even as they step up efforts to support employment and improve social welfare. "The financial burden that elderly care generates for Chinse households ... is one of major current constraints to reducing precautionary savings and boosting domestic consumption," said Alfredo Montufar-Helu, a Beijing-based advisor to multinational enterprises. Seniors will be assessed for their physical disability, and only those evaluated as "moderately, severely or completely disabled" will be allowed to claim such subsidies, according to the official statement. The allowances are currently set between 500 yuan and 800 yuan a month and can be used to pay for a portion of the costs for certain senior-care services, such as meal and bathing assistance, rehabilitation and day care. Details of the plan may be further "optimized" as authorities will run a pilot in select cities this month before a nationwide roll-out later this year. The scheme will last for 12 months. The measures could incentivize the adoption of such senior care services and ease the "hefty elderly care burden" for family members, said Tianchen Xu, senior economist at Economist Intelligence Unit. Echoing that view, Lynn Song, chief economist for Greater China at ING, said that while "strengthening of the social safety net has been one of the main goals in order to better unlock consumption, these measures can be interpreted as steps in this direction." As China's population ages and middle-class consumers facing job uncertainty scale back spending, the so-called silver economy — a sector that provides goods and services for people over 50 — has been on the rise, with more businesses targeting seniors who have accumulated sufficient retirement funds. "It's crucial for the government to keep pushing forward with reforms and strategies that tackle the deeper structural [supply-demand] imbalances," Montufar-Helu said. The fiscal aid will be primarily funded by the central government, with local authorities contributing a smaller share, according to the statement Wednesday. "Elder care is a key component of the country's broader services consumption ... the initiative is designed to foster new growth drivers and better align economic development with social welfare," the statement reads, translated by CNBC. Economists have ramped up calls for Beijing to prioritize policies aimed at strengthening the country's social safety net to tackle the aging population, high youth jobless rate and tepid domestic consumption. "Mounting demographic and economic pressures are forcing Beijing to highlight the social policy agenda in the upcoming 15th five-year plan," Eurasia Group said in a note Thursday. "Bolstering the social safety net, especially through changes to pensions and healthcare, is high on the agenda to adapt to a rapidly graying society," Eurasia Group said in a note Thursday. About 22% of China's population was aged 60 or older at the end of 2024, the statement said, up from 18.7% in 2020. The population aged 65 years and above in China reached 216.8 million in 2023, accounting for 15% of the total population.

Tariffs Weigh on Eli Lilly Stock (LLY) Ahead of Earnings
Tariffs Weigh on Eli Lilly Stock (LLY) Ahead of Earnings

Business Insider

time34 minutes ago

  • Business Insider

Tariffs Weigh on Eli Lilly Stock (LLY) Ahead of Earnings

U.S. President Donald Trump's threats to impose tariffs on the pharmaceutical industry are weighing on Eli Lilly's (LLY) stock ahead of its second-quarter financial results on Aug. 7. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The pharma sector had hoped that healthcare would be spared from President Trump's tariffs. However, that no longer appears to be the case with the Trump administration threatening import duties of up to 200%, news that has been a drag on Eli Lilly and other pharmaceutical stocks. So far, Eli Lilly has responded to the looming tariff threat by announcing that it will invest $27 billion to build four new manufacturing plants in the U.S. as demand for its weight-loss and diabetes drugs soars and the company develops new medications. Manufacturing Base The U.S. is already Eli Lilly's manufacturing base. Since 2020, the Indiana-based company has committed $50 billion to bolster its U.S. manufacturing. That investment has helped ease drug supply shortages of its popular prescription medications. Management at Eli Lilly has said that the majority of the company's drugs are made in America. Still, the looming threat of steep tariffs on the pharma sector has been weighing on LLY stock heading into the company's earnings, where expectations are high for strong sales and profits from the weight-loss drugs. LLY stock has risen 4% this year, underperforming the benchmark S&P 500 index. Is LLY Stock a Buy? The stock of Eli Lilly has a consensus Strong Buy rating among 19 Wall Street analysts. That rating is based on 16 Buy, two Hold, and one Sell recommendations issued in the last 12 months. The average LLY price target of $1,006.80 implies 26.07% upside from current levels.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store